NCT00015964View on ClinicalTrials.gov

ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

September 30, 2001

Study Completion Date

July 31, 2005

Conditions
Head and Neck Cancer
Interventions
DRUG

ZD1839

Trial Locations (11)

46617

Michiana Hematology/Oncology P.C., South Bend

49085

Oncology Care Associates, P.L.L.C., Saint Joseph

60153

Loyola University Medical Center, Maywood

60201

Evanston Northwestern Health Care, Evanston

60426

Ingalls Memorial Hospital, Harvey

60525

Columbia LaGrange Memorial Hospital, LaGrange

60640

Louis A. Weiss Memorial Hospital, Chicago

61602

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

62526

Cancer Care Specialists of Central Illinois, S.C., Decatur

60637-1470

University of Chicago Cancer Research Center, Chicago

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00015964 - ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck | Biotech Hunter | Biotech Hunter